PLA2G2E anticorps (Middle Region)
Aperçu rapide pour PLA2G2E anticorps (Middle Region) (ABIN928126)
Antigène
Voir toutes PLA2G2E AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- PLA2 G2 antibody was raised in rabbit using the middle region of PLA2 2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PLA2G2E Blocking Peptide, (ABIN938711), is also available for use as a blocking control in assays to test for specificity of this PLA2G2E antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PLA2G2E (Phospholipase A2, Group IIE (PLA2G2E))
-
Autre désignation
- PLA2G2E
-
Sujet
- PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.PLA2G2E has a preference for arachidonic-containing phospholipids. Synonyms: Polyclonal PLA2G2E antibody, Anti-PLA2G2E antibody, phospholipase A2, group IIE antibody.
-
Pathways
- Inositol Metabolic Process
Antigène
-